Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
A diverse set of biological processes have been implicated in the pathophysiology of Alzheimer’s disease (AD) and related dementias. However, there is limited understanding of the peripheral biological mechanisms relevant in the earliest phases of the disease. Here, we used a large-scale proteomics platform to examine the association of 4877 plasma proteins with 25-year dementia risk in 10,981 middle-aged adults. We found 32 dementia-associated plasma proteins that were involved in proteostasis, immunity, synaptic function, and extracellular matrix organization. We then replicated the association between 15 of these proteins and clinically relevant neurocognitive outcomes in two independent cohorts. We demonstrated that 12 of these 32 dementia-associated proteins were associated with cerebrospinal fluid (CSF) biomarkers of AD , neurodegeneration, or neuroinflammation. We found that eight of these candidate protein markers were abnormally expressed in human postmortem brain tissue from patients with AD, although some of the proteins that were most strongly associated with dementia risk, such as GDF15, were not detected in these brain tissue samples. Using network analyses, we found a protein signature for dementia risk that was characterized by dysregulation of specific immune and proteostasis/autophagy pathways in adults in midlife ~20 years before dementia onset, as well as abnormal coagulation and complement signaling ~10 years before dementia onset. Bidirectional two-sample Mendelian randomization genetically validated nine of our candidate proteins as markers of AD in midlife and inferred causality of SERPINA3 in AD pathogenesis. Last, we prioritized a set of candidate markers for AD and dementia risk prediction in midlife.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Bowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
Verbanck, M., Chen, C.-Y., Neale, B., & Do, R. (2018) · Nature Genetics · doi:10.1038/s41588-018-0099-7 · Cited by 8,591
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
KEGG as a reference resource for gene and protein annotation
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387
A general framework for estimating the relative pathogenicity of human genetic variants
Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., & Shendure, J. (2014) · Nature Genetics · doi:10.1038/ng.2892 · Cited by 6,183
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724
Lecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678
The GTEx Consortium atlas of genetic regulatory effects across human tissues
The GTEx Consortium, Aguet, F., Anand, S., Ardlie, K. G., Gabriel, S., Getz, G. A., Graubert, A., Hadley, K., Handsaker, R. E., Huang, K. H., et al. (2020) · Science · doi:10.1126/science.aaz1776 · Cited by 5,547
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Instrumental Variables Regression with Weak Instruments
Staiger, D., & Stock, J. (1994) · doi:10.3386/t0151 · Cited by 5,302
The Global Deterioration Scale for assessment of primary degenerative dementia
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 4,986
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess, S., & Thompson, S. G. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0255-x · Cited by 4,571
Giambartolomei, C., Vukcevic, D., Schadt, E. E., Franke, L., Hingorani, A. D., Wallace, C., & Plagnol, V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004383 · Cited by 4,261
Estimating glomerular filtration rate from serum creatinine and cystatin C
Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102
Self-citationFunctional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
New insights on the genetic etiology of Alzheimer’s and related dementia
(2020) · doi:10.1101/2020.10.01.20200659 · Cited by 2,499
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498
Self-citation23andMe Research Team, Lee, J. J., COGENT (Cognitive Genomics Consortium), Social Science Genetic Association Consortium, Wedow, R., Okbay, A., Kong, E., Maghzian, O., Zacher, M., Nguyen-Viet, T. A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0147-3 · Cited by 2,470
Zhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., Vogel, H., Steinberg, G. K., Edwards, M. S. B., Li, G., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.013 · Cited by 2,295
Genomic atlas of the human plasma proteome
Sun, B. B., Maranville, J. C., Peters, J. E., Stacey, D., Staley, J. R., Blackshaw, J., Burgess, S., Jiang, T., Paige, E., Surendran, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0175-2 · Cited by 2,268
Machiela, M. J., & Chanock, S. J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv402 · Cited by 2,069
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · cited 1×
“Increasingly, it is recognized that Aβ and tau represent two components of a highly complex and heterogeneous disease process (8) and that AD often co-occurs with other molecular and vascular pathology also known to contribute to cognitive decline (9).”
BackgroundTRANSFAC(R): transcriptional regulation, from patterns to profiles
Matys, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg108 · Cited by 1,985
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
EPIC- InterAct Consortium, Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G., & Thompson, S. G. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0011-z · Cited by 1,803
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · cited 1×
“However, AD genome-wide association studies (GWAS) suggest a complex biology that extends beyond amyloid and tau accumulation (1).”
BackgroundInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354 · cited 1×
“GDF15 is highly expressed by senescent cells as a core feature of the senescenceassociated secretory phenotype (30), a prolonged proinflammatory cellular state associated with age-related diseases (31).”
BackgroundYanai, I., Benjamin, H., Shmoish, M., Chalifa-Caspi, V., Shklar, M., Ophir, R., Bar-Even, A., Horn-Saban, S., Safran, M., Domany, E., et al. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti042 · Cited by 1,300
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Fromer, M., Roussos, P., Sieberts, S. K., Johnson, J. S., Kavanagh, D. H., Perumal, T. M., Ruderfer, D. M., Oh, E. C., Topol, A., Shah, H. R., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4399 · Cited by 1,091
Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice
Villeda, S. A., Plambeck, K. E., Middeldorp, J., Castellano, J. M., Mosher, K. I., Luo, J., Smith, L. K., Bieri, G., Lin, K., Berdnik, D., et al. (2014) · Nature Medicine · doi:10.1038/nm.3569 · Cited by 1,081
Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001
Comprehensive functional genomic resource and integrative model for the human brain
Wang, D., Liu, S., Warrell, J., Won, H., Shi, X., Navarro, F. C. P., Clarke, D., Gu, M., Emani, P., Yang, Y. T., et al. (2018) · Science · doi:10.1126/science.aat8464 · Cited by 965
Self-citationBowden, J., Spiller, W., Del Greco M, F., Sheehan, N., Thompson, J., Minelli, C., & Davey Smith, G. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy101 · Cited by 880
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Zheng, J., Haberland, V., Baird, D., Walker, V., Haycock, P., Hurle, M., Gutteridge, A., Erola, P., Liu, Y., Luo, S., et al. (2019) · doi:10.1101/627398 · Cited by 812
A robust and efficient method for Mendelian randomization with hundreds of genetic variants
Burgess, S., Foley, C. N., Allara, E., Staley, J. R., & Howson, J. M. M. (2020) · Nature Communications · doi:10.1038/s41467-019-14156-4 · Cited by 681
Co-regulatory networks of human serum proteins link genetics to disease
Emilsson, V., Ilkov, M., Lamb, J. R., Finkel, N., Gudmundsson, E. F., Pitts, R., Hoover, H., Gudmundsdottir, V., Horman, S. R., Aspelund, T., et al. (2018) · Science · doi:10.1126/science.aaq1327 · Cited by 680
Mapping the proteo-genomic convergence of human diseases
Pietzner, M., Wheeler, E., Carrasco-Zanini, J., Cortes, A., Koprulu, M., Wörheide, M. A., Oerton, E., Cook, J., Stewart, I. D., Kerrison, N. D., et al. (2021) · Science · doi:10.1126/science.abj1541 · Cited by 657 · cited 1×
“In support of these findings, largescale proteogenomic studies have identified systemic circulating factors, namely, proteins, as drivers of complex CNS diseases (6, 7).”
BackgroundAssociation Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650
Self-citationGenetic variability in the regulation of gene expression in ten regions of the human brain
UK Brain Expression Consortium, Ramasamy, A., North American Brain Expression Consortium, Trabzuni, D., Guelfi, S., Varghese, V., Smith, C., Walker, R., De, T., Coin, L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3801 · Cited by 644
Gottesman, R. F., Albert, M. S., Alonso, A., Coker, L. H., Coresh, J., Davis, S. M., Deal, J. A., McKhann, G. M., Mosley, T. H., Sharrett, A. R., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1658 · Cited by 633
Self-citationDysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620 · cited 1×
“Gene lists were based on GWAS catalog summary statistics [by Yang and colleagues (49)] and recent AD GWAS (14).”
MethodA multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research
De Jager, P. L., Ma, Y., McCabe, C., Xu, J., Vardarajan, B. N., Felsky, D., Klein, H.-U., White, C. C., Peters, M. A., Lodgson, B., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.142 · Cited by 598
The ARIC (Atherosclerosis Risk In Communities) Study
Wright, J. D., Folsom, A. R., Coresh, J., Sharrett, A. R., Couper, D., Wagenknecht, L. E., Mosley, T. H., Ballantyne, C. M., Boerwinkle, E. A., Rosamond, W. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.035 · Cited by 552
Self-citationPlasma protein patterns as comprehensive indicators of health
Williams, S. A., Kivimaki, M., Langenberg, C., Hingorani, A. D., Casas, J. P., Bouchard, C., Jonasson, C., Sarzynski, M. A., Shipley, M. J., Alexander, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0665-2 · Cited by 506
Self-citationβ2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis
Smith, L. K., He, Y., Park, J.-S., Bieri, G., Snethlage, C. E., Lin, K., Gontier, G., Wabl, R., Plambeck, K. E., Udeochu, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3898 · Cited by 500
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 493
Self-citationSniekers, S., Stringer, S., Watanabe, K., Jansen, P. R., Coleman, J. R. I., Krapohl, E., Taskesen, E., Hammerschlag, A. R., Okbay, A., Zabaneh, D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3869 · Cited by 490
Yousef, H., Czupalla, C. J., Lee, D., Chen, M. B., Burke, A. N., Zera, K. A., Zandstra, J., Berber, E., Lehallier, B., Mathur, V., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0440-4 · Cited by 442
ReactomeGSA - Efficient Multi-Omics Comparative Pathway Analysis
Griss, J., Viteri, G., Sidiropoulos, K., Nguyen, V., Fabregat, A., & Hermjakob, H. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir120.002155 · Cited by 390
Association of midlife to late-life blood pressure patterns with incident dementia
Walker, K. A., Sharrett, A. R., Wu, A., Schneider, A. L. C., Albert, M., Lutsey, P. L., Bandeen-Roche, K., Coresh, J., Gross, A. L., Windham, B. G., et al. (2019) · JAMA · doi:10.1001/jama.2019.10575 · Cited by 376
Self-citationHigginbotham, L., Ping, L., Dammer, E. B., Duong, D. M., Zhou, M., Gearing, M., Hurst, C., Glass, J. D., Factor, S. A., Johnson, E. C. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz9360 · Cited by 367
Higginbotham, L., Ping, L., Dammer, E. B., Duong, D. M., Zhou, M., Gearing, M., Johnson, E. C. B., Hajjar, I., Lah, J. J., Levey, A. I., et al. (2019) · doi:10.1101/806752 · Cited by 367
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Aguet, F., Barbeira, A. N., Bonazzola, R., Brown, A., Castel, S. E., Jo, B., Kasela, S., Kim-Hellmuth, S., Liang, Y., Oliva, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/787903 · Cited by 366
The BrainSeq Consortium, Jaffe, A. E., Straub, R. E., Shin, J. H., Tao, R., Gao, Y., Collado-Torres, L., Kam-Thong, T., Xi, H. S., Quan, J., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0197-y · Cited by 364
Sniekers, S., Stringer, S., Watanabe, K., Jansen, P. R., Coleman, J. R. I., Krapohl, E., Taskesen, E., Hammerschlag, A. R., Okbay, A., Zabaneh, D., et al. (2017) · Nature Genetics · doi:10.1038/ng1017-1558c · Cited by 333
Sieberts, S. K., Perumal, T. M., Carrasquillo, M. M., Allen, M., Reddy, J. S., Hoffman, G. E., Dang, K. K., Calley, J., Ebert, P. J., Eddy, J., et al. (2020) · Scientific Data · doi:10.1038/s41597-020-00642-8 · Cited by 318
Knopman, D. S., Gottesman, R. F., Sharrett, A. R., Wruck, L. M., Windham, B. G., Coker, L., Schneider, A. L. C., Hengrui, S., Alonso, A., Coresh, J., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.002 · Cited by 313
Self-citationYang, C., Farias, F. H. G., Ibanez, L., Suhy, A., Sadler, B., Fernandez, M. V., Wang, F., Bradley, J. L., Eiffert, B., Bahena, J. A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00886-6 · Cited by 290
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
Deming, Y., Filipello, F., Cignarella, F., Cantoni, C., Hsu, S., Mikesell, R., Li, Z., Del-Aguila, J. L., Dube, U., Farias, F. G., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau2291 · Cited by 271
The Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263
Genome-wide association study of Alzheimer's disease
Kamboh, M. I., Demirci, F. Y., Wang, X., Minster, R. L., Carrasquillo, M. M., Pankratz, V. S., Younkin, S. G., Saykin, A. J., Initiative, F. T. A. D. N., Jun, G., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.45 · Cited by 247 · cited 1×
“Supporting these findings, a genetic locus near MMP12 (rs12808148) that we identified as a pQLT for plasma MMP12 has been associated with AD risk previously (15).”
BackgroundLarge-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
Walker, K. A., Chen, J., Zhang, J., Fornage, M., Yang, Y., Zhou, L., Grams, M. E., Tin, A., Daya, N., Hoogeveen, R. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00064-0 · Cited by 212 · cited 10×
“ARIC quality control steps have been outlined in detail previously (11) and are described in the Supplementary Materials and Methods.”
BackgroundMethodInfluentialSelf-citationSystemic factors as mediators of brain homeostasis, ageing and neurodegeneration
Pluvinage, J. V., & Wyss-Coray, T. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0255-9 · Cited by 191 · cited 5×
“In addition, results from clinical and translational research indicate that systemic factors and biological processes outside the CNS can influence the risk for dementia and AD specifically (2).”
BackgroundInfluentialBehl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhas, C., Judea-Pusta, C., Uivarosan, D., Munteanu, M. A., & Bungau, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 186
Hage, C., Michaëlsson, E., Linde, C., Donal, E., Daubert, J.-C., Gan, L.-M., & Lund, L. H. (2017) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.116.001633 · Cited by 174
Cognitive decline in the elderly: an analysis of population heterogeneity
Hayden, K. M., Reed, B. R., Manly, J. J., Tommet, D., Pietrzak, R. H., Chelune, G. J., Yang, F. M., Revell, A. J., Bennett, D. A., & Jones, R. N. (2011) · Age and Ageing · doi:10.1093/ageing/afr101 · Cited by 168
Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
Wingo, A. P., Fan, W., Duong, D. M., Gerasimov, E. S., Dammer, E. B., Liu, Y., Harerimana, N. V., White, B., Thambisetty, M., Troncoso, J. C., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0635-5 · Cited by 161
Knopman, D. S., Griswold, M. E., Lirette, S. T., Gottesman, R. F., Kantarci, K., Sharrett, A. R., Jack, C. R., Graff-Radford, J., Schneider, A. L. C., Windham, B. G., et al. (2015) · Stroke · doi:10.1161/strokeaha.114.007847 · Cited by 160
Self-citationLoewenstein, Y., Portugaly, E., Fromer, M., & Linial, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn174 · Cited by 147
GCKD Investigators, Schlosser, P., Li, Y., Sekula, P., Raffler, J., Grundner-Culemann, F., Pietzner, M., Cheng, Y., Wuttke, M., Steinbrenner, I., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0567-8 · Cited by 137
Self-citationGuanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer
Honkala, A. T., Tailor, D., & Malhotra, S. V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03139 · Cited by 118
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Bos, I., Vos, S., Vandenberghe, R., Scheltens, P., Engelborghs, S., Frisoni, G., Molinuevo, J. L., Wallin, A., Lleó, A., Popp, J., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0396-5 · Cited by 112
Tin, A., Yu, B., Ma, J., Masushita, K., Daya, N., Hoogeveen, R. C., Ballantyne, C. M., Couper, D., Rebholz, C. M., Grams, M. E., et al. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027086 · Cited by 106
Self-citationFuchs, T., Trollor, J. N., Crawford, J., Brown, D. A., Baune, B. T., Samaras, K., Campbell, L., Breit, S. N., Brodaty, H., Sachdev, P., et al. (2013) · Aging Cell · doi:10.1111/acel.12116 · Cited by 103
Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
Younes, L., Albert, M., Moghekar, A., Soldan, A., Pettigrew, C., & Miller, M. I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00074 · Cited by 92 · cited 1×
“Subtle cognitive changes can occur well before the onset of dementia and may represent the earliest clinical manifestations of a neurodegenerative disease (17).”
BackgroundHelleman, J., Smid, M., Jansen, M. P. H. M., van der Burg, M. E. L., & Berns, E. M. J. J. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.010 · Cited by 90
Cognitive decline in old age: Separating retest effects from the effects of growing older.
Wilson, R. S., Li, Y., Bienias, L., & Bennett, D. A. (2006) · Psychology and Aging · doi:10.1037/0882-7974.21.4.774 · Cited by 78
Lindbohm, J. V., Mars, N., Walker, K. A., Singh‐Manoux, A., Livingston, G., Brunner, E. J., Sipilä, P. N., Saksela, K., Ferrie, J. E., Lovering, R. C., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12419 · Cited by 70
Self-citationMansour, H. M., Fawzy, H. M., El-Khatib, A. S., & Khattab, M. M. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.06.013 · Cited by 67 · cited 1×
“EGFR was recently identified as a candidate risk gene for AD in a larger GWAS (14), and previous work has implicated this protein in multiple neuropathological processes, including reactive astrocytosis, neuroinflammation, and axonal degradation (34).”
BackgroundKamboh, M. I., Minster, R. L., Kenney, M., Öztürk, A., Desai, P. P., Kammerer, C. M., & DeKosky, S. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.015 · Cited by 64
Deficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal Death
Konishi, Y., Yang, L., He, P., Lindholm, K., Lu, B., Li, R., & Shen, Y. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2582-13.2014 · Cited by 59
Reactome from a WikiPathways Perspective
Bohler, A., Wu, G., Kutmon, M., Pradhana, L. A., Coort, S. L., Hanspers, K., Haw, R., Pico, A. R., & Evelo, C. T. (2016) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004941 · Cited by 46
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
Fissolo, N., Matute-Blanch, C., Osman, M., Costa, C., Pinteac, R., Miró, B., Sanchez, A., Brito, V., Dujmovic, I., Voortman, M., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000941 · Cited by 40 · cited 1×
“SERPINA3, also known as alpha-1-antichymotrypsin, is a peptidase inhibitor that has been previously associated with AD, AD age of onset (13), and primary progressive multiple sclerosis (24).”
BackgroundKunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Self-citationInflammation induces serine protease inhibitor 3 expression in the rat pineal gland
Takamiya, A., Takeda, M., Yoshida, A., & Kiyama, H. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00198-7 · Cited by 28 · cited 1×
“SERPINA3 is upregulated in the context of inflammation (25) and can promote the assembly of Aβ peptides into filaments (26).”
BackgroundSchlosser, P., Knaus, J., Schmutz, M., Döhner, K., Plass, C., Bullinger, L., Claus, R., Binder, H., Lübbert, M., & Schumacher, M. C. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2983010 · Cited by 28
Self-citationLong‐term risk of dementia following hospitalization due to physical diseases: A multicohort study
Sipilä, P. N., Lindbohm, J. V., Singh‐Manoux, A., Shipley, M. J., Kiiskinen, T., Havulinna, A. S., Vahtera, J., Nyberg, S. T., Pentti, J., & Kivimäki, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12167 · Cited by 24
Self-citationVeroni, C., Serafini, B., Rosicarelli, B., Fagnani, C., Aloisi, F., & Agresti, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00190 · Cited by 22
Up-regulation of calsyntenin-3 by β-amyloid increases vulnerability of cortical neurons
Uchida, Y., Nakano, S.-I., Gomi, F., & Takahashi, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.025 · Cited by 18 · cited 5×
“However, there were several proteins, including synaptic protein CLSTN3 and immune protein SERPINA3, which demonstrated a much stronger associations with dementia risk in men, and adhesion/ECM protein FBLN and growth factor IGFBP2, which showed a much stronger association with dementia risk in women.”
BackgroundInfluentialMohammadnejad, A., Nygaard, M., Li, S., Zhang, D., Xu, C., Li, W., Lund, J., Christiansen, L., Baumbach, J., Christensen, K., et al. (2020) · Aging · doi:10.18632/aging.104198 · Cited by 14 · cited 1×
“Genetic variation in the gene coding for GRID2, an ionotropic glutamate receptor, has been associated with intelligence (36), cognition (37), and educational attainment (38).”
BackgroundDevelopmental and genetic regulation of the human cortex transcriptome in schizophreniaPreprint
Jaffe, A. E., Straub, R. E., Shin, J. H., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/124321 · Cited by 13
Walker, K. A., Chen, J., Wu, A., Tin, A., Mosley, T. H., Fornage, M., Ballantyne, C. M., Boerwinkle, E., Sullivan, K., Zeger, S. L., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.038307 · Cited by 2
Self-citationReisberg, B., Ferris, S. H., de Leon, M. J., & Crook, T. (1982) · PsycTESTS Dataset · doi:10.1037/t48466-000
Research works printed but not linked: 1
- 10.1038/s41588-020-0682-6 · doi:10.1038/s41588-020-0682-6 · Paper page
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Plasma proteomic profiles predict future dementia in healthy adults
Guo, Y., You, J., Zhang, Y., Liu, W.-S., Huang, Y.-Y., Zhang, Y.-R., Zhang, W., Dong, Q., Feng, J.-F., Cheng, W., et al. (2024) · Nature Aging · doi:10.1038/s43587-023-00565-0 · Cited by 293
“No statistical methods were used to predetermine sample size, but our sample size is similar to or even higher than those reported in previous publications 18,53 .”
MethodResultDohm-Hansen, S., English, J. A., Lavelle, A., Fitzsimons, C. P., Lucassen, P. J., & Nolan, Y. M. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.02.001 · Cited by 122
“…analysis of samples taken at middle age revealed synaptic, proteostatic, and immune-and microglia-related proteins that were associated with incident dementia 25 years later, neuroimaging-derived phenotypes 5 years later (e.g., white matter hyperintensities), and CSF in fl ammatory load [33,34].”
BackgroundInfluentialChadarevian, J. P., Hasselmann, J., Lahian, A., Capocchi, J. K., Escobar, A., Lim, T. E., Le, L., Tu, C., Nguyen, J., Kiani Shabestari, S., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.023 · Cited by 83
Plasma proteomics identify biomarkers and undulating changes of brain aging
Liu, W., You, J., Chen, S.-D., Zhang, Y., Feng, J., Xu, Y., Yu, J., & Cheng, W. (2024) · Nature Aging · doi:10.1038/s43587-024-00753-6 · Cited by 102
“Plasma GFAP was significantly associated with risk of incident ACD (HR = 2.066, P = 2.23 × 10 −76 ), AD (HR = 2.393, P = 1.59 × 10 −71 ) and VD (HR = 2.281, P = 4.66 × 10 −29 ).”
Influential
Metadata
- Authors
- Walker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., Peng, Z., Gomez, G. T., Tin, A., Hoogeveen, R. C., Sullivan, K. J., Ganz, P., Lindbohm, J. V., Kivimaki, M., Nevado-Holgado, A. J., Buckley, N., Gottesman, R. F., Mosley, T. H., Boerwinkle, E., Ballantyne, C. M., & Coresh, J.
- Affiliations
- National Institute on Aging (US)
- Johns Hopkins University (US)
- Novo Nordisk Research Centre Oxford (NNRCO), Oxford OX3 7FZ, UK.
- Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21210, USA.
- University of Mississippi Medical Center (US)
- Baylor College of Medicine (US)
- University of California, San Francisco (US)
- Broad Institute (US)
- Department of Mental Health of Older People, Faculty of Brain Sciences, University College London, London WC1E 6BT, UK.
- Department of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.
- University of Oxford (GB)
- National Institute of Neurological Disorders and Stroke (US)
- Corresponding author
- Walker, Keenan A.
- Coresh, Josef
- ORCID
- Walker, Keenan A.
- Shi, Liu
- Yang, Yunju
- Fornage, Myriam
- Schlosser, Pascal
- Surapaneni, Aditya
- Grams, Morgan E.
- Duggan, Michael R.
- Peng, Zhongsheng
- Gomez, Gabriela T.
- Tin, Adrienne
- Hoogeveen, Ron C.
- Sullivan, Kevin J.
- Ganz, Peter
- Lindbohm, Joni V.
- Kivimaki, Mika
- Nevado-Holgado, Alejo J.
- Buckley, Noel
- Gottesman, Rebecca F.
- Mosley, Thomas H.
- Boerwinkle, Eric
- Ballantyne, Christie M.
- Coresh, Josef
- Venue
- Science Translational Medicine
- Published
- 2023-07-19
- Volume
- 15
- Issue
- 705
- Pages
- eadf5681-eadf5681
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10665113
- OpenAlex
- W4384819023
- Cited by
- 148
- References
- 103
- Citations by year
- 2026: 42 · 2025: 56 · 2024: 39 · 2023: 11
- FWCI
- 29.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- GlaxoSmithKline
- Wellcome Trust (221854/Z/20/Z, 350426)
- European Commission (H2020 SC1, H2020)
- Rosetrees Trust
- Deutsche Forschungsgemeinschaft (192904750, CRC992)
- Albert-Ludwigs-Universität Freiburg
- Päivikki ja Sakari Sohlbergin Säätiö
- National Institutes of Health (5u01hl096899-08, 5u01hl096902-08, S011676, Z99 AG999999, H2020)
- Gillings School of Public Health
- Horizon 2020 Framework Programme (H2020-SC1)
- Medical Research Council (S011676, MR/R024227/1, MR/S011676/1, MRC S011676)
- Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg
- National Institute on Aging (U01AG058589, RF1AG062553, U01AG052409, R01AG056477, RF1AG059421, ZIAAG000349, ZIAAG000348, P30AG066546)
- National Heart, Lung, and Blood Institute (HHSN268201700004I, HHSN268201700001I, HHSN268201700005C, HHSN268201700003I, U01HL096814, U01-HL-096899, R01HL087641, R01HL059367, R01HL134320, HHSN268201700005I, U01-HL-096902, HHSN268201700001C, U01HL096917, HHSN268201700002I, HHSN268201700003C, HHSN268201700002C, R01HL070825, HHSN268201700004C, U01HL096812, K24HL155861, R01HL086694)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124399, R01DK100446, R01DK115534, R01DK108803)
- National Institute of Neurological Disorders and Stroke
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR073178)
- National Center for Research Resources (UL1RR025005)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, dementia risk, plasma proteins, biomarkers, proteomics, middle-aged adults, proteostasis, autophagy, neuroinflammation, cerebrospinal fluid biomarkers, GDF15, alpha-1-antichymotrypsin, coagulation, complement signaling, neurodegeneration, synaptic function, extracellular matrix, neuropsychological outcomes, dementia risk prediction
- MeSH terms
- Adult, Alzheimer Disease, Brain, Humans, Middle Aged, Biomarkers, Amyloid beta-Peptides, tau Proteins, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.